s6y

Biological Products, (No Diagnostic Substances)

183 listed companies the SEC classes under this industry (code 2836), in order of revenue.

166 of them have annual figures on record. The 158 reporting in US dollars had revenue of $96.6B between them in their latest fiscal years.

Company Fiscal year to
Amgen Inc Dec 2025 $36.8B$7.71B$90.6B
Gilead Sciences, Inc. Dec 2025 $29.4B$8.51B$59.0B
Biogen Inc. Dec 2025 $9.89B$1.29B$29.4B
Neurocrine Biosciences Inc Dec 2025 $2.86B$478.6M$4.63B
Exelixis, Inc. Jan 2026 $2.32B$782.6M$2.84B
Qiagen N.V. Dec 2025 $2.09B$424.9M$6.28B
Moderna, Inc. Dec 2025 $1.94B−$2.82B$12.3B
Halozyme Therapeutics, Inc. Dec 2025 $1.40B$316.9M$2.53B
Bio-Techne Corp Jun 2026 $1.22B$181.9M$2.59B
Novavax Inc Dec 2025 $1.12B$440.3M$1.18B
Biocryst Pharmaceuticals Inc Dec 2025 $874.8M$263.9M$514.2M
Repligen Corp Dec 2025 $738.3M$48.9M$2.95B
Adma Biologics, Inc. Dec 2025 $510.2M$146.9M$624.2M
Twist Bioscience Corp Sep 2026 $459.4M−$130.2M$1.12B
Tarsus Pharmaceuticals, Inc. Dec 2025 $451.4M−$66.4M$562.2M
Immunocore Holdings plc Dec 2025 $400.0M−$35.5M$1.07B
Krystal Biotech, Inc. Dec 2025 $389.1M$204.8M$1.33B
Adaptive Biotechnologies Corp Dec 2025 $277.0M−$59.5M$512.7M
Vericel Corp Dec 2025 $276.3M$16.5M$488.0M
Iovance Biotherapeutics, Inc. Dec 2025 $263.5M−$391.0M$913.2M
Vaxart, Inc. Dec 2025 $237.3M$16.3M$186.1M
Adaptimmune Therapeutics PLC Dec 2024 $178.0M−$70.8M$246.0M
Regenxbio Inc. Dec 2025 $170.4M−$193.9M$453.0M
Ginkgo Bioworks Holdings, Inc. Dec 2025 $170.2M−$312.8M$1.12B
Beam Therapeutics Inc. Dec 2025 $139.7M−$80.0M$1.48B
Monte Rosa Therapeutics, Inc. Dec 2025 $123.7M−$38.6M$448.7M
Atara Biotherapeutics, Inc. Dec 2025 $120.8M$32.7M$20.2M
Agenus Inc Dec 2025 $114.2M−$3.08M$226.8M
ImmunityBio, Inc. Dec 2025 $113.3M−$351.4M$501.9M
Century Therapeutics, Inc. Dec 2025 $109.2M−$9.58M$223.7M
Sutro Biopharma, Inc. Dec 2025 $102.5M−$191.1M$173.8M
4D Molecular Therapeutics, Inc. Dec 2025 $85.2M−$140.1M$566.7M
MeiraGTx Holdings plc Dec 2025 $81.4M−$114.2M$244.4M
Autolus Therapeutics plc Dec 2025 $75.4M−$287.5M$589.1M
Recursion Pharmaceuticals, Inc. Dec 2025 $74.7M−$644.8M$1.47B
Cellectis S.A. Dec 2025 $72.9M−$67.6M$324.7M
Compugen Ltd Dec 2025 $72.8M$35.3M$156.6M
Black Diamond Therapeutics, Inc. Dec 2025 $70.0M$22.4M$143.0M
Vir Biotechnology, Inc. Dec 2025 $68.6M−$438.0M$1.00B
Champions Oncology, Inc. Apr 2026 $59.4M−$1.18M$27.0M
Invivyd, Inc. Dec 2025 $53.4M−$52.5M$276.9M
Protalix BioTherapeutics, Inc. Dec 2025 $52.7M−$6.60M$82.3M
Fennec Pharmaceuticals Inc. Dec 2025 $44.6M−$9.74M$70.6M
Editas Medicine, Inc. Dec 2025 $40.5M−$160.1M$186.5M
Voyager Therapeutics, Inc. Dec 2025 $40.4M−$119.7M$252.3M
Sangamo Therapeutics, Inc Dec 2025 $39.6M−$122.9M$59.7M
Kymera Therapeutics, Inc. Dec 2025 $39.2M−$311.4M$1.74B
C4 Therapeutics, Inc. Dec 2025 $35.9M−$105.0M$359.1M
X4 Pharmaceuticals, Inc Dec 2025 $35.1M−$79.2M$290.5M
Precision Biosciences Inc Dec 2025 $34.3M−$45.7M$154.4M
Scilex Holding Co Dec 2025 $30.3M−$374.1M$365.0M
Metagenomi Therapeutics, Inc. Dec 2025 $25.2M−$87.9M$221.1M
Alector, Inc. Dec 2025 $21.0M−$142.9M$293.2M
LENZ Therapeutics, Inc. Dec 2025 $19.1M−$82.1M$305.9M
Mesoblast Ltd Jun 2025 $17.2M−$102.1M$784.7M
Pelthos Therapeutics Inc. Dec 2025 $16.8M−$43.3M$130.4M
Relay Therapeutics, Inc. Dec 2025 $15.4M−$276.5M$621.3M
Lineage Cell Therapeutics, Inc. Dec 2025 $14.6M−$63.5M$112.6M
Caribou Biosciences, Inc. Dec 2025 $11.2M−$148.1M$175.4M
TScan Therapeutics, Inc. Dec 2025 $10.3M−$129.8M$228.8M
Alpha Cognition Inc. Dec 2025 $10.2M−$20.7M$79.7M
Taysha Gene Therapies, Inc. Dec 2025 $9.77M−$109.0M$343.3M
Curis Inc Dec 2025 $9.44M−$7.58M$20.0M
Evaxion A/S Dec 2025 $7.53M−$7.71M$28.4M
Fate Therapeutics Inc Dec 2025 $6.65M−$136.3M$318.9M
DBV Technologies S.A. Dec 2025 $5.64M−$146.9M$233.7M
Zeo ScientifiX, Inc. Oct 2025 $5.20M−$5.52M$1.53M
Prime Medicine, Inc. Dec 2025 $4.63M−$201.1M$342.7M
Ocugen, Inc. Dec 2025 $4.41M−$67.8M$43.5M
CG Oncology, Inc. Dec 2025 $4.04M−$161.0M$791.6M
CRISPR Therapeutics AG Dec 2025 $3.51M−$581.6M$2.27B
Surrozen, Inc. Dec 2025 $3.48M−$242.0M$98.7M
Dyadic International Inc Dec 2025 $3.09M−$7.36M$9.95M
Aligos Therapeutics, Inc. Dec 2025 $2.19M−$24.2M$88.5M
Humacyte, Inc. Dec 2025 $2.04M−$40.8M$116.4M
Outlook Therapeutics, Inc. Sep 2025 $1.41M−$62.4M$18.6M
Scinai Immunotherapeutics Ltd. Dec 2025 $1.31M−$8.31M$11.6M
Inhibrx Biosciences, Inc. Dec 2025 $1.30M−$140.1M$146.5M
Pluri Inc. Jun 2026 $1.02M−$23.8M$24.9M
Prokidney Corp. Dec 2025 $893.0K−$69.0M$335.6M
ImageneBio, Inc. Dec 2025 $800.0K−$45.3M$153.0M
Cardiff Oncology, Inc. Dec 2025 $593.0K−$45.9M$61.9M
aTYR PHARMA Inc Dec 2025 $190.0K−$74.1M$93.0M
Zivo Bioscience, Inc. Dec 2024 $157.2K−$13.4M$1.64M
VivoSim Labs, Inc. Mar 2026 $131.0K−$13.8M$7.39M
AIM ImmunoTech Inc. Dec 2025 $88.0K−$14.0M$5.78M
Inmune Bio Inc. Dec 2025 $50.0K−$45.9M$32.4M
Entera Bio Ltd. Dec 2025 $42.0K−$11.4M$16.0M
Opthea Ltd Jun 2025 $25.0K−$162.8M$56.8M
Senti Biosciences Holdings, Inc. Dec 2025 $22.0K−$61.4M$51.2M
Creative Medical Technology Holdings, Inc. Dec 2025 $6.00K−$6.00M$7.81M
Argenx SE Dec 2020 –−€528.9M€1.86B
Revolution Medicines, Inc. Dec 2025 –−$1.13B$2.35B
BioNTech SE Dec 2025 –−€1.14B€22.0B
Vaxcyte, Inc. Dec 2025 –−$766.6M$3.00B
Immunovant, Inc. Mar 2026 –−$505.6M$957.0M
Kodiak Sciences Inc. Dec 2025 –−$230.0M$351.5M
Scholar Rock Holding Corp Dec 2025 –−$377.9M$404.3M
Denali Therapeutics Inc. Dec 2025 –−$512.5M$1.14B
Replimune Group, Inc. Mar 2026 –−$313.9M$332.4M
Maze Therapeutics, Inc. Dec 2025 –−$131.1M$397.1M
Alvotech Dec 2025 –$27.9M$1.49B
Vor Biopharma Inc. Dec 2025 –−$696.0M$464.1M
Immatics N.V. Dec 2025 –−€196.4M€562.3M
Aura Biosciences, Inc. Dec 2025 –−$106.2M$169.4M
Solid Biosciences Inc. Dec 2025 –−$174.3M$232.5M
Cullinan Therapeutics, Inc. Dec 2025 –−$219.9M$448.4M
Sana Biotechnology, Inc. Dec 2025 –−$244.2M$416.9M
Valneva SE Dec 2025 €174.7M−€115.2M€398.8M
IRulya Therapeutics Inc. Dec 2025 –−$84.0M$93.5M
Tectonic Therapeutic, Inc. Dec 2025 –−$74.2M$261.0M
Tevogen Inc. Dec 2025 –−$26.3M$4.38M
Candel Therapeutics, Inc. Dec 2025 –−$38.2M$125.2M
Kyverna Therapeutics, Inc. Dec 2025 –−$161.3M$293.8M
SAB Biotherapeutics, Inc. Dec 2025 –$13.3M$172.8M
Lexeo Therapeutics, Inc. Dec 2025 –−$100.0M$268.7M
Allogene Therapeutics, Inc. Dec 2025 –−$190.9M$415.9M
Cabaletta Bio, Inc. Dec 2025 –−$167.9M$165.1M
Artiva Biotherapeutics, Inc. Dec 2025 –−$83.9M$130.9M
Inhibikase Therapeutics, Inc. Dec 2025 –−$48.3M$181.2M
Palisade Bio, Inc. Dec 2025 –−$16.8M$134.3M
Protara Therapeutics, Inc. Dec 2025 –−$57.4M$209.5M
Compass Therapeutics, Inc. Dec 2025 –−$66.5M$219.6M
enGene Therapeutics Inc. Oct 2025 –−$117.3M$221.5M
Cardiol Therapeutics Inc. Dec 2025 –−C$33.8MC$23.6M
Armata Pharmaceuticals, Inc. Dec 2025 –−$173.8M$76.9M
Innate Pharma SA Dec 2025 €9.01M−€49.2M€62.7M
Molecular Partners AG Dec 2025 –−CHF 61.7MCHF 102.1M
Zura Bio Ltd Dec 2025 –−$68.7M$113.9M
Neumora Therapeutics, Inc. Dec 2025 –−$236.9M$191.0M
Tenaya Therapeutics, Inc. Dec 2025 –−$90.6M$146.9M
Viskase Holdings, Inc. Dec 2025 –−$3.41M$42.8M
Anavex Life Sciences Corp. Sep 2025 –−$46.4M$103.8M
Coherus Oncology, Inc. Dec 2025 –$168.0M$258.3M
OKYO Pharma Ltd Mar 2025 –−$4.71M$3.68M
Cognition Therapeutics Inc Dec 2025 –−$23.5M$48.4M
MiNK Therapeutics, Inc. Dec 2025 –−$12.5M$14.2M
Eloxx Pharmaceuticals, Inc. Dec 2025 –−$6.00M$5.27M
Greenland Mines Ltd Dec 2025 –−$10.6M$9.59M
Instil Bio, Inc. Dec 2025 –−$71.4M$203.5M
Elutia Inc. Dec 2025 –$53.4M$62.4M
Exozymes Inc. Dec 2025 –−$9.16M$5.97M
Kalaris Therapeutics, Inc. Dec 2025 –−$43.4M$121.7M
LeonaBio, Inc. Dec 2025 –−$105.6M$92.2M
Genenta Science S.p.A. Dec 2025 –−€6.53M€31.9M
Vesicor Therapeutics Holdings, Inc. Nov 2025 –$1.33M$23.9M
CEL SCI Corp Sep 2025 –−$25.4M$28.2M
Estrella Immunopharma, Inc. Dec 2025 –−$13.1M$3.18M
Acumen Pharmaceuticals, Inc. Dec 2025 –−$121.3M$122.8M
Jasper Therapeutics, Inc. Dec 2025 –−$75.8M$35.8M
Passage BIO, Inc. Dec 2025 –−$45.5M$62.3M
BioCardia, Inc. Dec 2025 –−$8.23M$3.41M
Brainstorm Cell Therapeutics Inc. Dec 2025 –−$10.3M$1.02M
Intensity Therapeutics, Inc. Dec 2025 –−$11.6M$14.1M
IN8BIO, Inc. Dec 2025 –−$19.4M$32.3M
Liminatus Pharma, Inc. Dec 2025 –−$10.2M$512.8K
Abpro Holdings, Inc. Dec 2025 –−$2.89M$1.06M
PharmaCyte Biotech, Inc. Apr 2026 –−$19.4M$46.8M
BioAtla, Inc. Dec 2025 –−$59.6M$13.8M
Calidi Biotherapeutics, Inc. Dec 2025 –−$19.9M$8.86M
Agentix Corp. Mar 2026 –−$485.6K$771
Silexion Therapeutics Corp Dec 2025 –−$11.9M$7.21M
Green Planet Bio Engineering Co. Ltd. Dec 2025 –−$35.8K–
Mosaic ImmunoEngineering Inc. Dec 2025 –−$687.8K$19.9K
Cero Therapeutics Holdings, Inc. Dec 2025 –−$19.9M$3.64M
Adaptin Bio, Inc. Dec 2025 –−$5.17M$619.2K
Hemab Therapeutics Holdings, Inc.
Lycia Therapeutics, Inc.
Windward Bio Group AG
Odyssey Therapeutics, Inc.
Bambusa Therapeutics, Inc.
Attovia Therapeutics, Inc.
Iambic Therapeutics, Inc.
Electra Therapeutics, Inc.
SL Science Holding Ltd
AgomAb Therapeutics NV
TRex Bio, Inc.
Eikon Therapeutics, Inc.
Scribe Therapeutics, Inc.
BioStem Technologies, Inc.
Scancell Holdings plc
Talawar Tx Inc.
Curative Biotechnology Inc

Each company's latest fiscal year, as its annual report to the SEC gave the figures; the year links to that report. Amounts in other currencies are not converted, and sort after those in dollars.